LONDON, Friday, May 02,
2003
Two studies from the US and Europe, published in The Lancet,
follow another piece of research that appeared earlier this
week suggesting that, on the contrary, a high-fibre diet
may not necessarily prevent bowel cancer.
In one of the latest studies, Dr Ulrike Peters and colleagues
from the National Cancer Institute in Rockville, US, assessed
the relationship between fibre intake and frequency of colorectal
adenomas – non-malignant polyps which are often a precursor
of malignant disease.
Their investigation of around 34,000 people who did not have
polyps and 3,600 who had at least one adenoma in either the
colon or rectum revealed that a high intake of fibre, particularly
from grains, cereals and fruit, was associated with a lower
risk of colorectal adenoma.
Those who were in the top 20 per cent for dietary fibre intake
had a 27 per cent lower risk of adenomas compared to people
in the bottom 20 per cent for fibre intake.
Appearing in the same journal, a European study reaches similar
conclusions after looking at dietary fibre intake and the
incidence of colorectal cancer in more than half a million
people aged 25 to 70 years of age.
After an average follow-up of 4.5 years, 1,065 cases of colorectal
cancer were diagnosed.
People who ate 35g of dietary fibre per day reduced their
risk of colorectal cancer by as much as 40 per cent compared
with those who consumed only 15g per day, according to the
team of doctors from across Europe.
Professor Nick Day, who led the European study for Cancer
Research UK, says, “It became clear that the amount
of dietary fibre in food was inversely related to bowel cancer
incidence.”
However, Professor Sheila Bingham of the Medical Research
Council, which helped to fund the study, warns, “It
is important for people to be aware that fibre supplements
or special foods with added fibre were not studied and it
should not be assumed that they have the same protective
effect as foods that are naturally rich in fibre such as
cereals, vegetables and fruit.”
Source: The Lancet 2003;
361: 1491-1501
©
HMG Worldwide 2003